Mycobacterium abscessus and other nontuberculous mycobacteria: Evolving respiratory pathogens in cystic fibrosis: A case report and review

Southern Medical Journal

Volumn 98, Issue 6, 2005, Pages 657-661

  Hayes Jr , Don ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Cystic fibrosis; Mycobacterium abscessus; Nontuberculous mycobacteria

Indexed keywords

ADOLESCENT; BACTERIAL COLONIZATION; BACTERIAL OVERGROWTH; BACTERIAL VIRULENCE; BRONCHIECTASIS; BRONCHUS SECRETION; CASE REPORT; CYSTIC FIBROSIS; DETERIORATION; FEMALE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LUNG TRANSPLANTATION; MYCOBACTERIOSIS; MYCOBACTERIUM; MYCOBACTERIUM ABSCESSUS; NONHUMAN; PATHOGENICITY; PREVALENCE; PSEUDOMONAS AERUGINOSA; REVIEW; RISK FACTOR; SPUTUM; SYMPTOMATOLOGY; THORAX SCINTISCANNING;

ADOLESCENT; ANTI-BACTERIAL AGENTS; BRONCHIECTASIS; CYSTIC FIBROSIS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LUNG DISEASES; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS; SPUTUM; STAPHYLOCOCCAL INFECTIONS;

EID: 20544473809     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.SMJ.0000163311.70464.91     Document Type: Review

References (31)

1. Davis PB, Drumm M, Konstan MW. State of the art: CF. Am J Resp Crit Care Med 1996;154:1229-1256.
2. Burns JL, Emerson J, Stapp JR, et al. Microbiology of sputum from patients at cystic fibrosis centers in the United States. Clin Infect Dis 1998;27:158-163.
3. Burns JL, Saiman L. Burkholderia cepacia infections in cystic fibrosis. Pediatr Infect Dis J 1999;18:155-156.
4. Olivier KN, Yankaskas JR, Knowles MR. Nontuberculous mycobacterial pulmonary disease in cystic fibrosis. Semin Respir Infect 1996;11: 272-284.
5. Falkinham JO. Epidemiology of infection by nontuberculous mycobacteria. Clin Micro Rev 1996;9:177-215.
6. Kourbeti IS, Maslow MJ. Nontuberculous mycobacteria infections of the lung. Curr Infect Dis Rep 2000;2:193-200.
7. Ebert DL, Olivier KN. Nontuberculous mycobacteria in the setting of cystic fibrosis. Clin Chest Med 2002;23:655-663.
8. Hjelte L, Petrini B, Kallenius G, et al. Prospective study of mycobacterial infections in patients with CF. Thorax 1990;45:397-400.
9. Hjelt K, Hojlyng N, Howitz P, et al. The role of mycobacteria other than tuberculosis (MOTT) in patients with CF. Scand J Infect Dis 1994;26: 569-576.
10. Hudson ME. Bacterial infection in CF: special reference to mycobacteria and Burkholderia cepacia. Pediatr Pulmonol Suppl 1995;11:66-67.
11. Fauroux B, Delaisi B, Clement A, et al. Mycobacterial lung disease in CF: a prospective study. Pediatr Infect Dis J 1997;16:354-358.
12. Olivier KN, Weber DJ, Wallace RJ Jr, et al. Nontuberculous mycobacteria, I: multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med 2003;167:828-834.
13. Whittier S, Hopfer RL, Knowles MR, et al. Improved recovery of mycobacteria from respiratory secretions of patients with CF. J Clin Microbiol 1993;31:861-864.
14. Whittier S, Olivier K, Gilligan P, et al. Proficiency testing of clinical microbiology laboratories using modified decontamination procedures for detection of nontuberculous mycobacteria in sputum samples from CF patients. J Clin Microbiol 1997;35:2706-2708.
15. Bange FC, Kirschner P, Bottger EC. Recovery of mycobacteria from patients with CF. J Clin Microbiol 1999;37:3761-3762.
16. Official statement of the American Thoracic Society approved by the Board of Directors, Diagnosis and treatment of disease caused by non-tuberculous mycobacteria. Am J Respir Crit Care Med 1997;156:S1-S25.
17. Griffith DE, Girard WM, Wallace RJ Jr. Clinical features of pulmonary disease caused by rapidly growing mycobacteria: an analysis of 154 patients. Am Rev Respir Dis 1993;147:1271-1278.
18. Peloquin CA. Serum concentrations of the antimycobacterial drugs. Chest 1998;113:1154-1155.
19. Wallace RJ, Brown BA, Griffith DE, et al. Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease. Am J Respir Crit Care Med 1994;149:1335-1341.
20. Wallace RJ, Brown BA, Griffith DE, et al. Clarithromycin regimens for pulmonary Mycobacterium avium complex. Am J Respir Crit Care Med 1996;153:1762-1772.
21. Cullen AR, Cannon CL, Mark EJ, et al. Mycobacterium abscessus infection in CF. Am J Respir Crit Care Med 2000;161:641-645.
22. Colin AA. Eradication of Mycobacterium abscessus in a chronically infected patient with cystic fibrosis. Pediatr Pulmonol 2000;30:267-268.
23. Brown-Elliot BA, Wallace RJ Jr. Clarithromycin resistance in Mycobacterium abscessus. J Clin Microbiol 2001;39:2745-2746.
24. Tebas P, Sultan F, Wallace RJ Jr, et al. Rapid development of resistance to clarithromycin following monotherapy for disseminated Mycobacterium chelonae infection in a heart transplant patient. Clin Infect Dis 1995;20:443-444.
25. Wallace RJ Jr, Meier A, Brown BA, et al. Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus. Antimicrob Agents Chemother 1996;40:1676-1681.
26. Wallace RJ, Tanner D, Brennan PJ, et al. Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae. Ann Intern Med 1993;119:482-486.
27. Wallace RJ Jr, Brown-Elliott BA, Ward SC, et al. Activities of Linezolid against rapidly growing mycobacteria. Antimicrob Agents Chemother 2001;45:764-767.
28. Brown-Elliott BA, Wallace RJ Jr, Blinkhorn R, et al. Successful treatment of disseminated Mycobacterium chelonae infection with linezolid. Clin Infect Dis 2001;33:1433-1434.
29. Malouf MA, Glanville AR. The spectrum of mycobacterial infection after lung transplantation. Am J Respir Crit Care Med 1999;160:1611-1616.
30. Sanguinetti M, Ardito F, Fiscarelli E, et al. Fatal pulmonary infection due to multidrug-resistant Mycobacterium abscessus in a patient with cystic fibrosis. J Clin Microbiol 2001;39:816-819.
31. Fairhurst RM, Kubak BM, Shpiner RB, et al. Mycobacterium abscessus empyema in a lung transplant recipient. J Heart Lung Transplant 2002; 21:391-394.